Interleukin‐6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease‐modifying antirheumatic drugs: The tocilizumab in combination with traditional disease‐modifying antirheumatic drug therapy study
Genovese, Mark C. ; McKay, James D. ; Nasonov, Evgeny L. ; Mysler, Eduardo F. ; da Silva, Nilzio A. ; Alecock, Emma ; Woodworth, Thasia ; Gomez‐Reino, Juan J.
Arthritis and rheumatism, 2008-10, Vol.58 (10), p.2968-2980Hoboken: Wiley Subscription Services, Inc., A Wiley Company
Texto completo disponível
Anterior
Página Inicial
RSS
Feed
Políticas
Fale Conosco-
Realização:
Logos de Redes Sociais: 